Aditxt, Inc. Sale Leaseback Transaction, Gross Proceeds, Financing Activities
Aditxt, Inc. (ADTX) reported Sale Leaseback Transaction, Gross Proceeds, Financing Activities of $4.47 million for the 0-month period ending 2023-10-05, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:SaleLeasebackTransactionGrossProceedsFinancingActivities · last filed 2024-05-20
- 2023-10-05: Sale Leaseback Transaction, Gross Proceeds, Financing Activities 0 month $4.47M; Sale Leaseback Transaction, Gross Proceeds, Financing Activities $4.47M.
| Period end | Sale Leaseback Transaction, Gross Proceeds, Financing Activities 0 month | Sale Leaseback Transaction, Gross Proceeds, Financing Activities |
|---|---|---|
| 2023-10-05 | $4.47M 10-K · filed 2024-04-16 | $4.47M 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |